ArticleGeroScience2026
Association of physical activity with incident dementia and cognitive decline among Australian older adults.
Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We investigated the association between physical activity (PA) intensity and dementia and cognitive decline in Australian community-dwelling older adults. This prospective cohort study uses data from 11,655 older adults (mean age (standard deviation, SD) = 75.0 (4.2) years, 53.4% females, 52.9% had completed ≥ 12 years of education), who were participants in the ASPirin in Reducing Events in the Elderly (ASPREE) clinical trial and its observational follow-on (ASPREE-XT) and the ASPREE Longitudinal Study of Older Persons (ALSOP) sub-study. Participants self-reported the exposure of usual PA intensity (never/rarely, light, moderate, vigorous). Dementia was adjudicated using the Diagnostic Manual of Mental Disorders 4th Edition and supporting evidence; cognitive decline was defined as a > 1.5 standard deviation reduction from baseline on any cognitive assessment. Associations were explored using hazard ratios from Cox regression models with adjustment for demographic, socio-economic, behavioural and clinical factors. Of 11,655 participants (mean age 75.0 years) over a median 10.4-year follow-up, 931 (8.0%) developed dementia and 3552 (30.8%) cognitive decline. Compared with light PA, dementia or cognitive decline risk was 79% (95% CI 1.14-2.83) and 58% (95% CI 1.21-2.05) higher, respectively, among those who rarely/never engaged in PA, but no further decreases occurred with higher levels of PA. Engagement in light PA may help lower dementia and cognitive decline risk in older adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.